Literature DB >> 23483018

FDG PET or PET/CT in evaluation of renal angiomyolipoma.

Chun-Yi Lin1, Hui-Yi Chen, Hueisch-Jy Ding, Kuo-Yang Yen, Chia-Hung Kao.   

Abstract

OBJECTIVE: Angiomyolipoma is the most common benign kidney tumor. However, literature describing FDG PET findings on renal angiomyolipoma (AML) is limited. This study reports the FDG PET and PET/CT findings of 21 cases of renal AML.
MATERIALS AND METHODS: The study reviews FDG PET and PET/CT images of 21 patients diagnosed with renal AML. The diagnosis is based on the classical appearance of an AML on CT scan with active surveillance for 6 months. The study is focused on the observation of clinical and radiographic features.
RESULTS: Six men and 15 women were included in our study. The mean age of the patients was 57.14 ± 9.67 years old. The mean diameter of 21 renal AML on CT scans was 1.76 ± 1.00 cm (Min: 0.6 cm; Max: 4.4 cm). CT scans illustrated renal masses typical of AMLs, and the corresponding FDG PET scans showed minimal FDG activities in the area of the tumors. None of the 21 AMLs showed a maximum standardized uptake value (SUV(max)) greater than 1.98. No statistically significant correlation was present between SUV(max) and tumor size.
CONCLUSION: Renal AMLs demonstrate very low to low uptake on FDG PET and PET/CT imaging in this study. When a fat-containing tumor in the kidney is found on a CT scan, it is critical to differentiate an AML from a malignant tumor including an RCC, liposarcoma, and Wilms tumor. This study suggests that FDG PET or PET/CT imaging is useful for differentiating a renal AML from a fat-containing malignant tumor.

Entities:  

Keywords:  Computed tomography; Fluorine-18 fluoro-2-deoxy-D-glucose; Positron emission tomography; Renal angiomylipoma

Mesh:

Substances:

Year:  2013        PMID: 23483018      PMCID: PMC3590350          DOI: 10.3348/kjr.2013.14.2.337

Source DB:  PubMed          Journal:  Korean J Radiol        ISSN: 1229-6929            Impact factor:   3.500


  20 in total

1.  PET scan with 11C-acetate for the imaging of liver masses: report of a false positive case.

Authors:  R Lhommel; L Annet; A Bol; J-F Gigot; C Sempoux; I Mathieu; M Seret; M Lonneux
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-05       Impact factor: 9.236

2.  [Positron emission tomography in diagnosis of renal cell carcinoma].

Authors:  R Bachor; J Kotzerke; H W Gottfried; E Brändle; S N Reske; R Hautmann
Journal:  Urologe A       Date:  1996-03       Impact factor: 0.639

Review 3.  CT evaluation of renovascular disease.

Authors:  A Kawashima; C M Sandler; R D Ernst; E P Tamm; S M Goldman; E K Fishman
Journal:  Radiographics       Date:  2000 Sep-Oct       Impact factor: 5.333

Review 4.  Imaging of angiomyolipomas.

Authors:  L Lemaitre; M Claudon; F Dubrulle; E Mazeman
Journal:  Semin Ultrasound CT MR       Date:  1997-04       Impact factor: 1.875

Review 5.  Renal angiomyolipoma during pregnancy: review of the literature.

Authors:  Ignacio Zapardiel; Jesus Delafuente-Valero; Jose Manuel Bajo-Arenas
Journal:  Gynecol Obstet Invest       Date:  2011-08-27       Impact factor: 2.031

6.  Cancer statistics, 2007.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2007 Jan-Feb       Impact factor: 508.702

Review 7.  Renal angiomyolipomata.

Authors:  John J Bissler; J Chris Kingswood
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

8.  Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma.

Authors:  David E Kang; Richard L White; James H Zuger; Howell C Sasser; Chris M Teigland
Journal:  J Urol       Date:  2004-05       Impact factor: 7.450

9.  Angiomyolipoma: computed tomographic-pathologic correlation of 17 cases.

Authors:  J L Sherman; D S Hartman; A C Friedman; J E Madewell; C J Davis; S M Goldman
Journal:  AJR Am J Roentgenol       Date:  1981-12       Impact factor: 3.959

10.  Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells.

Authors:  Aimee L Edinger; Corinne M Linardic; Gary G Chiang; Craig B Thompson; Robert T Abraham
Journal:  Cancer Res       Date:  2003-12-01       Impact factor: 12.701

View more
  6 in total

Review 1.  Renal angiomyolipoma without visible fat: Can we make the diagnosis using CT and MRI?

Authors:  Robert S Lim; Trevor A Flood; Matthew D F McInnes; Luke T Lavallee; Nicola Schieda
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

2.  Clinical presentation, management, and outcome of patients with incidental renal angiomyolipoma in qatar.

Authors:  Hassan Al-Thani; Ayman El-Menyar; Maryam Al-Sulaiti; Jamela El-Mabrok; Khairi Hajaji; Hesham Elgohary; Ahmed Al-Malki; Abdelhakem Tabeb
Journal:  Oman Med J       Date:  2014-11

Review 3.  Molecular imaging of urogenital diseases.

Authors:  Steve Y Cho; Zsolt Szabo
Journal:  Semin Nucl Med       Date:  2014-03       Impact factor: 4.446

Review 4.  WARM N COLD: malignant and benign renal tumors in children.

Authors:  Thomas Ray Sanchez; Jonathan Ducore; Jay Balagtas; Christopher Molloy; Sandra L Wootton-Gorges
Journal:  Emerg Radiol       Date:  2014-02-26

5.  Importance of Defect Detectability in Positron Emission Tomography Imaging of Abdominal Lesions.

Authors:  Shozo Yamashita; Kunihiko Yokoyama; Masahisa Onoguchi; Haruki Yamamoto; Tetsu Nakaichi; Shiro Tsuji; Kenichi Nakajima
Journal:  Asia Ocean J Nucl Med Biol       Date:  2015

6.  Author reply.

Authors:  Venkatraman Indiran
Journal:  Indian J Radiol Imaging       Date:  2017 Apr-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.